Negovsky Reanimatology Research Institute Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02133638
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Negovsky Reanimatology Research Institute | Negovsky Reanimatology Research Institute, Moscow, Russia | V. Negovskij Reanimatology Research Institute RAMS

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 3)

Delirium (Phase 4)

Heart Arrest (Phase 4)

Hypoxia (Phase 4)

Hypoxia, Brain (Phase 4)

Respiratory Distress Syndrome (Phase 3)

Respiratory Distress Syndrome, Newborn (Phase 3)

Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 8